Skip to the page

Data / Form D filings / ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd.: Form D filings

ImmunoPrecise Antibodies Ltd., a pharmaceuticals company in Victoria, British Columbia, Canada, filed 4 Form D notices with the SEC between 2017 and 2024. The latest, on July 30, 2024, reports $2 million sold of a $3 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3204 - 4464 Markham Street, Victoria, British Columbia, Canada, V8Z 7
Phone
(604) 806-0626
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
British Columbia, Canada
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1715925

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 30, 2024New notice$3,000,000$2,000,000$1,000,0001Jul 16, 2024sec.gov
Oct 9, 2018New notice$768,848$341,710$427,1385Sep 24, 2018sec.gov
Jul 9, 2018New notice$17,034$7,571$9,4631Jun 18, 2018sec.gov
Aug 31, 2017New notice$133,875$133,8757Aug 16, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Chris BuyseDirector
Kristin TaylorExecutive Officer
Dirk WittersDirector
Ilse RoodnikExecutive Officer
Mitch LevineDirector
Barry SpringerDirector
Jennifer BathDirector, Executive Officer

Every Form D from the week of Jul 29, 2024 · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what ImmunoPrecise Antibodies Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.